Skip to main content
main-content

Devices and technology

Specific populations

10-16-2019 | Artificial pancreas systems | News

iDCL trial shows sustained time in range improvement with hybrid closed-loop delivery

People with type 1 diabetes using the Tandem Control-IQ hybrid closed-loop insulin delivery system spent significantly more time within their target blood glucose range than people using a sensor-augmented insulin pump during 6 months of use in the iDCL trial.

08-08-2019 | Continuous glucose monitoring | News

Pros and cons of CGM described by parents of children with diabetes

Continuous glucose monitoring offers many benefits to the families of young children with type 1 diabetes but also a number of challenges that cannot always be overcome, show results of a qualitative analysis conducted in the USA.

07-05-2019 | Continuous glucose monitoring | News

ATTD consensus group releases time in range recommendations

A statement from an ATTD consensus group has streamlined previously agreed continuous glucose monitoring metrics and set out time in range targets.

05-31-2019 | Children | News

High variability in insulin needs complicates diabetes management in young children

Children with type 1 diabetes who are aged 6 years or younger have significantly more variability in their insulin needs than adolescents or adults, shows an analysis of closed-loop data.

05-03-2019 | Devices and technology | Editorial | Article

Exposure to diabetes technologies: Where now for adult services?

What does the proliferation of diabetes self-management and monitoring technologies in pediatric care mean for the future of adult services? Katharine Barnard looks at the situation in England and Wales.

04-04-2019 | Insulin pumps | Highlight | News

Randomized trial questions superiority of insulin pumps over injections in children

Insulin pumps and multiple daily injections deliver similar glycemic control and safety profiles when allocated alongside education and support at the point of type 1 diabetes diagnosis, say researchers.

03-25-2019 | Artificial pancreas systems | News

Real-world data highlight closed-loop frustrations for youth users

System problems and irritations lead to nearly two in five children abandoning use of closed-loop insulin delivery in a real-world setting, researchers have reported.

03-25-2019 | Hypoglycemia | News

Problem of hypoglycemia unawareness highlighted in older people with type 1 diabetes

Baseline data from the WISDM trial show that older adults with type 1 diabetes who have impaired awareness of hypoglycemia symptoms can spend over half an hour per day with extremely low blood glucose levels.

03-08-2019 | Pregnancy | DUKPC 2019 | News

CONCEPTT data show substantial cost savings with CGM in pregnancy

Using continuous glucose monitoring for all women with type 1 diabetes during pregnancy could save the UK National Health Service over 9 million pounds per year, report the CONCEPTT investigators.

02-28-2019 | Mobile technology | News

Engagement with mobile health intervention linked to improved glycemic control

Responsiveness to text message reminders about blood glucose monitoring is associated with glycemic benefit among adolescents with type 1 diabetes, study findings indicate.

02-26-2019 | Psychosocial care | ATTD 2019 | News

CGM at diabetes diagnosis improves family psychosocial outcomes

Giving children continuous glucose monitoring from the point of diabetes diagnosis gives their caregivers greater confidence to manage hypoglycemia and reduces their diabetes-related distress, shows a randomized trial.

02-22-2019 | Continuous glucose monitoring | ATTD 2019 | Article

Researcher comment: The benefits of starting CGM immediately after diabetes diagnosis

Korey Hood discusses his research looking at the effects on patients and carers of starting continuous glucose monitoring straight after diabetes diagnosis (4:25).

02-22-2019 | Psychosocial care | ATTD 2019 | Article

Psychosocial research in diabetes: An endocrinologist’s viewpoint

Tim Jones explains why psychosocial research matters to clinicians, and discusses a randomized trial of continuous glucose monitoring from the point of diabetes diagnosis (3:11).

02-22-2019 | Psychosocial care | ATTD 2019 | Article

Expert highlights: Psychologic issues influencing device uptake in teens with diabetes

Korey Hood outlines some psychologic issues that should be addressed to optimize the uptake of diabetes technologies by adolescents (4:46).

02-01-2019 | Artificial pancreas systems | News

Support for hybrid closed-loop insulin delivery in young children

Home use of day and night hybrid closed-loop insulin delivery using the Cambridge model predictive control algorithm is feasible in children aged 1–7 years with type 1 diabetes, researchers report.

12-14-2018 | Artificial pancreas systems | News

MD-Logic closed-loop system successful for unmonitored day and night use

The DREAM5 randomized trial has confirmed the efficacy of closed-loop insulin delivery with the MD-logic algorithm in adolescents and young adults without remote monitoring.

12-14-2018 | Risk factors | Feature | Article

Sleep duration: Waking up to a major metabolic risk factor

The effect of sleep duration on glucose regulation and cardiometabolic risk is becoming an increasingly high-profile issue. medwireNews takes a look at the latest evidence, which shows the gravity of the problem but also offers some solutions.

11-07-2018 | Pregnancy | News

Surprising CONCEPTT findings on insulin pumps versus injections in pregnant women

A prespecified analysis of the CONCEPTT trial shows that pregnant women with type 1 diabetes who were using pumps at baseline did not achieve as good glycemic control as those using multiple daily injections.

10-04-2018 | Artificial pancreas systems | EASD 2018 | News

‘Gold standard’ trial tests closed-loop delivery across the age spectrum

A randomized trial demonstrates the efficacy of closed-loop insulin delivery in a wide range of patients with poorly controlled type 1 diabetes.

Image Credits